These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1153264)

  • 41. New workers' compensation legislation: expected pharmaceutical cost savings.
    Wilson L; Gitlin M
    Am J Ind Med; 2005 Oct; 48(4):239-48. PubMed ID: 16142746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pharmacoeconomic aspects of bronchial asthma].
    Prosekova EV; Gel'tser BI; Shestovskaia TN
    Ter Arkh; 2000; 72(3):55-8. PubMed ID: 10776656
    [No Abstract]   [Full Text] [Related]  

  • 43. Developing a per diem hospital pharmacy charge.
    Pang F; Buck H; Brinkman J
    Am J Hosp Pharm; 1974 May; 31(5):476-8. PubMed ID: 4597821
    [No Abstract]   [Full Text] [Related]  

  • 44. Will Parcost ease the patient's financial burden?
    Can Hosp; 1970 Dec; 47(12):5-7. PubMed ID: 5495413
    [No Abstract]   [Full Text] [Related]  

  • 45. The cost of prescription drugs: rising concerns over equity, fairness and access to essential care.
    Work DR; Domino ME
    N C Med J; 2003; 64(6):270-4. PubMed ID: 14983614
    [No Abstract]   [Full Text] [Related]  

  • 46. [Costs of dental care and medical care paid by the patients].
    Holst D; Grytten J; Rossow I; Wang N
    Nor Tannlaegeforen Tid; 1990 Mar; 100(5):198-203. PubMed ID: 2119030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Analysis of our drug consumption in various so-called geriatrie diseases].
    Krankemann G
    Dtsch Gesundheitsw; 1968 Oct; 23(41):1938-40. PubMed ID: 5712783
    [No Abstract]   [Full Text] [Related]  

  • 48. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
    Morgan SG; Agnew JD; Barer ML
    Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cephalosporin prices rising in wake of Pryor bill.
    Barlow RD
    Hosp Mater Manage; 1991 Jul; 16(7):1, 12-3. PubMed ID: 10112311
    [No Abstract]   [Full Text] [Related]  

  • 50. Pricing pharmaceutical service--art, science or whim.
    Wertheimer AI
    J Am Pharm Assoc; 1973 Jan; 13(1):11-2. PubMed ID: 4682567
    [No Abstract]   [Full Text] [Related]  

  • 51. Determining a dispensing fee by cost accounting methods.
    Rodowskas CA
    J Am Pharm Assoc; 1973 Jan; 13(1):8-10 passim. PubMed ID: 4682580
    [No Abstract]   [Full Text] [Related]  

  • 52. [Price organization in pharmaceutical economics].
    Keĭz EB
    Farmatsiia; 1969; 18(4):8-10. PubMed ID: 5379663
    [No Abstract]   [Full Text] [Related]  

  • 53. [Consequences of changing from fixed amount payments to percentage payment of drugs].
    Berg SH; Aasmundstveit O; Saanum DT
    Tidsskr Nor Laegeforen; 1990 Oct; 110(26):3391-4. PubMed ID: 2256066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparisons of the costs of psychotropic medications: an update.
    Jurman RJ; Davis JM
    Psychiatr Med; 1991; 9(2):349-59. PubMed ID: 1677482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Price control on drugs in Norway].
    Halse M
    Nord Med; 1975 Mar; 90(3):92-3. PubMed ID: 1153264
    [No Abstract]   [Full Text] [Related]  

  • 56. [Price control on drugs].
    Nord Med; 1975 Mar; 90(3):91-2. PubMed ID: 1153263
    [No Abstract]   [Full Text] [Related]  

  • 57. [Drug prices and public control].
    Halse M
    Nord Med; 1975 Oct; 90(10):244-6. PubMed ID: 1187335
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.